Fact CheckerSign in

NCT04322461Completed

Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population

Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population : Pilot Project PARKA

Source: ClinicalTrials.gov · Last updated 3 Jun 2025

Brief summary (registry, in English)

A two months intervention in which two groups of cognitive disorders, Parkinson and Alzheimer's disease, will receive 50g/day of a commercial MCT supplement combined with supervised aerobic exercise 3 times/week. Cognition and ketones will be assess before and after the intervention, along with endocannabinoids plasma concentrations.

Status (registry)
Completed
Study type
Interventional
Enrollment
14 (actual)
First submitted
24 Mar 2020
Start date
1 May 2022
Primary completion date
27 May 2024
Lead sponsor
Université de Sherbrooke
NCT number
NCT04322461

What you commit to

  • Study type: Interventional
  • Participants enrolled: 14
  • From 1 May 2022 to the primary completion date, 27 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Coconut allergy
  • Cardiac disease
  • Any uncontrolled disease that could interfer with the project.

Other

  • MMSE \< 20
  • MCT or coconut oil supplementation
  • Cannabis, THC or CBD consumption
  • Excessive alcohol consumption
  • Physical activity 3x/week
  • Presence of an metallic object in the body
  • Impossibility to lay in dorsal decubitus for 40 minutes

Who the study is looking for

  • Alzheimer's or parkinson disease diagnostic
  • Stable medication associated with the disease
  • Able to consent
  • Presence of an accompanying person for the first and last visit.
  • Ability to read and talk in French

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre de recherche sur le vieillissement
Coordinator of this site? Confirm its status
SherbrookeCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.